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The adaptive immune system relies on diversity of its repertoire of receptors to protect the organism from a great variety of pathogens. Since
the initial repertoire is the result of random gene rearrangement, binding of receptors is not limited to pathogen-associated antigens but
also includes self antigens. There is a fine balance between having a diverse repertoire, protecting from many different pathogens, and
yet reducing its self-reactivity as far as possible to avoid damage to self. In the ageing immune system this balance is altered, manifesting
in reduced specificity of response to pathogens or vaccination on a background of higher self-reactivity. To answer the question whether
age-related changes of repertoire in the diversity and self/non-self affinity balance of antibodies could explain the reduced efficacy of the
humoral response in older people, we construct a minimal mathematical model of the humoral immune response. The principle of least
damage allows us, for a given repertoire of antibodies, to resolve a tension between the necessity to neutralise target antigens as quickly as
possible and the requirement to limit the damage to self antigens leading to an optimal dynamics of immune response. The model predicts
slowing down of immune response for repertoires with reduced diversity and increased self-reactivity.
adaptive immune response | immune repertoire | repertoire diversity | repertoire self-reactivity
The adaptive immune system relies on an extremely diverse repertoire of receptors that can recognise target moleculesto protect us from pathogens. Each cell has a unique specificity, encoded by the T cell receptor on T cells, or the B cell
receptor on B cells. In the case of B cells, the B cell receptor is also known as surface immunoglobulin, and this immunoglobulin
(Ig) can be secreted as antibody once the cell has developed into a plasma cell. Antibodies (Ab) are an important first line of
defence, they can block the action of harmful target molecules and help to recruit additional elements of the immune system by
acting as bridges between target molecules and effector cells. The targets of Ab are known as antigens (Ag).
B cells are formed in the bone marrow, where they acquire a unique Ig via gene rearrangement, a process that can produce
over 108 different genes by reassortment of less than 200 germline gene segments (1, 2). The highest diversity is seen in
the areas of the Ig gene where different gene segments are joined together, and these areas of the gene encode the parts
of the Ab that bind to Ag, thus ensuring a large diversity in the Abs structural forms of possible binding interactions (3).
Since gene rearrangement is essentially random, the potential binding interactions of the initial repertoire are not limited to
pathogen-associated target Ag, they can include self-Ag also. Immunological tolerance is a negative selection process whereby
B cells having Ig with strong binding to self are deleted from the repertoire so that they cannot develop into plasma cells
secreting self-reactive Abs (4). There is a trade-off between having a large enough shape space to be prepared for many different
pathogen-associated Ags and yet reducing self-reactivity as far as possible to avoid self-damage (5). During activation of B
cells in an immune response, the B cells with specificity for target Ag are expanded (6). With the advent of high throughput
sequencing methods, we can see that there are a broad range of antibodies that respond, even for simple antigens such as tetanus
toxin (7). The affinity for target Ag can be increased in germinal centres of secondary lymphoid tissue where B cells undergo
cycles of somatic hypermutation of their Ig genes, followed by competitive selection for the best target Ag-binders (8, 9). Thus,
the initial repertoire is altered by both positive and negative selection events, depending on binding to target and self Ags.
Older people are more susceptible to infection, in particular to bacterial infections such as pneumonia or urinary tract
infections (2). In the ageing immune system, the balance of the immune system is altered, manifested in a reduced specific
target Ab response to infection or vaccination on a background of a higher number of Abs showing evidence of self-reactivity (8).
In this instance, the presence of self-reactive Abs does not usually indicate autoimmune disease pathology, rather we believe it
may reflect an increased presence of ‘polyspecific’ or ‘promiscuous’ antibodies which have binding affinities that are measurable
for several different targets. Since we know that T cell availability and function is also compromised with age (10), it is possible
that the B cell repertoire is not receiving as much help to produce affinity-matured specific antibodies that can dominate the
immune response, relying instead on more T-independent responses. Increased use of IgG2 over IgG1 detected in the samples
of older patients supports this hypothesis (11). Analyses of older Ig gene repertoires indicate that selection events at different
stages of B cell development, both positive and negative, are less effective in the older immune system (2). Some Ig gene
characteristics that have been associated with polyspecificity are seen to be increased in the naïve B cell population of older
people (12). In addition, a reduction in the diversity of the B cell repertoire overall has also been seen in older people (13).
Our question is whether age-related repertoire changes in diversity and target/self-Ag affinity balance could explain the
reduced efficacy of the humoral response in older people. To this end we construct a minimal mathematical model of the
humoral immune response. The ingredients of this model are Abs, target Ag and self-Ag. Abs are binding the target Ag
and thus reduce the amount of free target Ag, i.e. Ag not bound by Abs. The amount of free target Ag plays a role of an
‘energy’ in our construction, and we assume that the immune system tries to minimise this energy. We note that various energy
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functions have been used in immune system modelling in the past, such as the ‘total affinity’ in somatic hypermutation of B
cells (14), or the ‘disagreement’ between the B and T cell signalling in lymphocyte ‘networks’ in more recent studies (15–17).
Furthermore, we assume that we have many types of Abs, each specified by its affinity to the targets and to self Ag (18), which
constitute the immune repertoire in our model. Immune repertoires were studied theoretically in e.g. (19, 20), and more recently
in (21). The role of self-Ags in shaping the diversity of repertoires, important for reliable self/non-self discrimination (19), was
emphasised in (20). We assume that both the binding of Abs to self-Ag and the presence of free target Ag incurs damage,
hence the unconstrained use of Abs is not possible and the amount of free target Ag has to be reduced. To resolve these two
conflicting requirements we develop the principle of least damage which allows us to derive an optimal dynamics of the immune
response. While the resulting theoretical framework is very general, even its simplest analytically solvable version predicts the
‘slowing down’ of the immune response for repertoires with reduced diversity and increased self-reactivity.
Mechanics of Immune Response
A simple thought experiment. To investigate the trade-off between antibody binding to a desired target, such as pathogen,
versus a self-damaging target, we consider the case where there are many antibodies responding to a challenge, in the absence of
a single dominating high-affinity antibody. Our thought experiment assumes that we have a finite volume reservoir containing
a finite amount of target antigen (Ag) and self-antigen (self-Ag) in some medium (see Figure 1). We also assume that we
are given M different types of antibodies (Abs), labelled by the integers 1 to M , which can be released into the reservoir.
The release of each Ab is controlled by a valve. We assume that the reservoir contents are well mixed. Abs released into the
reservoir react with both types of Ag, resulting in the formation of Ag-Ab complexes; thus the amount of ‘free’ (i.e. unbound)
Ag is reduced. The properties of Abs, such as how strongly they react with each Ag, etc., are assumed to be initially unknown.
Two gauges attached to the reservoir measure the amounts of free target Ag and of self-Ag. The opening and closing of valves,
and performing various measurements (such as of the amount of Abs delivered into the reservoir, the amount of free target Ag
and self-Ag in the reservoir) constitutes an ‘experiment’.
Measurement protocol. The experimental measurement is defined by a set of time points t0, . . . , tk−1, tk, . . . , tn together
with the flow rates rµ(t1), . . . , rµ(tk−1), rµ(tk), . . . , rµ(tn) recorded at these times, for each Ab µ (see Figure 1). We label
antibody types by Greek indices. The total amount of Ab µ released into the reservoir up to the time tk is given by the sum
bµ(tk) =
∑k
`=1 rµ(t`)(t` − t`−1). If the flow rates rµ(t) are smooth functions of time, each amount approaches an integral
bµ(tk) =
∫ tk
t0
rµ(t)dt in the limit where the measurement times become arbitrarily close, t` − t`−1 → 0. The system in Figure 1
is then fully described by the amounts of Abs b(t) = (b1(t), . . . , bM (t)), delivered into the reservoir up to time t, and the rates
d
dtb(t) =
( d
dt b1(t), . . . ,
d
dt bM (t)
)
of delivery of Abs. The amount of free target Ag, measured by the left gauge in Figure 1, is a
function AT (b(t)) of the Abs b(t). The same is true for AS(b), the amount of free self-Ag, measured by the right gauge in the
Figure 1. By construction, the total amount of free Ag in the experiment is a non-increasing function of time, i.e. ddtAT ≤ 0
and ddtAS ≤ 0.
Measurement of antibody affinity. Let the amount of free target Ag at time t0 be AT (b(t0)), and assume that at the next
time-point t1 we release into the reservoir a small amount ∆bµ of Ab µ, i.e. bµ(t1) = bµ(t0) + ∆bµ and bν(t1) = bν(t0) for all
ν 6= µ. The resulting change in the amount of free target Ag is given by ∆AµT = AT (b(t1))−AT (b(t0)) ≤ 0 and for ∆bµ → 0
we have (∂AT /∂bµ)(dbµ/dt) ≤ 0. The same holds for the free self-Ag AS(b). Upon releasing a single Ab into the reservoir
we will generally observe different behaviours of the gauges, which can be used to classify this Ab. Ab µ is more ‘reactive’
than Ab ν if ∆AµT ≤ ∆AνT , for ∆bµ = ∆bν , i.e. if the same amount of Ab reduces more Ag upon releasing type µ insterad of
ν . Similarly, Ab µ is more self-reactive than Ab ν when ∆AµS ≤ ∆AνS , and Ab µ is more reactive than self-reactive when
∆AµT ≤ ∆AµS (and vice versa). For ∆bµ → 0 all of the above definitions can implemented with partial derivatives, so Ab µ is
more reactive than self-reactive when (∂AT /∂bµ) ≤ (∂AS/∂bµ), etc.
Significance Statement
The older immune system is less able to protect us from infection and more likely to malfunction, and inappropriate inflammation
is involved in the aetiology of many diseases of old age. Since the world population is growing older, immune senescence is a
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Fig. 1. Immune Response: the Thought Experiment. Top drawing: antibodies (Abs) are released into a reservoir which contains a mixture of target antigen, Ag (red triangles)
and self-antigen, self-Ag (blue circles). They can form Ab-Ag complexes and thereby reduce the amount of free (i.e. unbound) Abs, target Ag and self-Ag. The latter two
amounts are measured, respectively, by the left and right ‘gauges’. The experiment is performed under constraints, such as finite duration and finite reservoir volume. Middle
drawing: the release of antibodies is controlled by the flow rate (vertical axis) at any given time (horizontal axis). The total amount of Ab released up to time tk (crosses) is
increasing with time. Bottom drawing: the amount of free target Ag (self-Ag) is decreasing with time. Each measurement is taken at the time-point sk with sk  tk , to ensure
that the mixture in the reservoir is always in equilibrium.
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The difference ∆AµT is related to the affinity of Ab µ (22), which is usually defined as the ratio rµ = K
+
µ /K
−
µ of
forward/backward rates of the chemical reaction Ag + Ab 
 AgAb. In chemical equilibrium the latter can be computed
experimentally, via the relation rµ = [AgAb]/[Ag][Ab], upon measuring the amount [Ag] of free target Ag, the amount [Ab] of
free Ab, and the amount [AgAb] of Ag-Ab complexes, in the absence of other antibodies or antigens. In our notation, the
affinity can be written as
rµ = − ([Ag]−[AgAb])−[Ag][Ab]−0
1
[Ag] = −
∆AµT
∆bµ
1
AT (0)
, [1]
evaluated at b = 0. Thus for ∆bµ → 0 it becomes the derivative
rµ(b) = −
(
∂
∂bµ
logAT (b)
)
b=0
. [2]
For b 6= 0, expression [2] can be seen as a generalised affinity, measured by adding a small amount of Ab µ in to the mixture of
Ags and Abs. The affinity to self-Ag rSµ (b) uses the same definition as [2], but with AS(b) instead of AT (b).
In immunology one commonly thinks in terms of a repertoire of different antibodies, each reacting to target-Ag or to self-Ag,
and of changing repertoires representing expansions of target-Ag antibodies in immune activation and deletion of self-Ag
antibodies in immune tolerance. However, single antibodies can bind to multiple different antigens, with varying affinity, and
these antigens could be either target-Ag or self-Ag. What we may have empirically determined to be a specific target-Ag
binding antibody may in fact be a polyspecific antibody where the binding to self-Ag is so small as to be unnoticed. So we
need to consider polyspecific antibodies, with variable affinities for binding to multiple Ag.
Using multiple antibody types to reduce free antigen. We assume here for simplicity that we have one type of target Ag, which
we seek to reduce using a repertoire of antibodies. The Ag has NA distinct regions which can be ‘recognised’ by Abs, the
epitopes. The Abs, represented by the amounts b = (b1, . . . , bM ), are assumed to interact with free epitopes, i.e. those not bound
by Abs. The amounts of the free epitopes are written as E = (E1, . . . , ENA). Each Ei ≡ Ei(b) must be a non-decreasing function
of the amount of Abs, such that 0 ≤ Ei(b) ≤ Ei(0). Furthermore, the ‘amount’ of free target antigen AT (b) ≡ AT (E (b)) ≥ 0
will similarly be a non-decreasing function of the amount of free epitopes.
We assume that the protocol used to reduce the amount of Ag takes the form of differential equations for the rates of
antibody delivery, given the amounts b ≡ b(t) of Abs in the reservoir (as in biological processes), i.e. that
d
dt bµ = fµ (b) [3]
For the dynamics [3] to reduce target Ag, it is sufficient that the rate functions fµ(b) are positive,
d
dtAT =
M∑
µ=1
∂AT
∂bµ
d
dt bµ = −AT (b)
M∑
µ=1
rµ(b)fµ (b) ≤ 0. [4]
Clearly, since AT (b) ≥ 0, the AT (b) is a Lyapunov function of [3]. The possible choices for the Ab delivery rate functions fµ(b)
are further restricted by physical constraints in the experiment, such as finite time, finite volume, finite amount of available
Abs, etc. Further complications occur if, in addition to target Ag, the reservoir also contains self Ag and, when we try to
reduce free target Ag, only a finite amount of reduced self Ag (off-target damage) can be tolerated. It is natural to assume
that the amount of free self Ag must depend in a similar way on the amount of free epitopes ES(b) = (ES1 (b), . . . , ESNS (b)) as
the target antigen, so AS(b) = AS
(ES(b)). Furthermore, one would expect that the Ab dynamics [3] is also a function of
self-epitopes, i.e.
d
dt bµ = fµ
(E(b),ES(b)), [5]
and that any biologically sensible choice fµ(. . .) must be an increasing function of E(b) and a decreasing function of ES(b).
Antibody Dynamics
Principle of least damage. Instead of guessing an equation for the Ab delivery rates fµ(. . .), we take a Darwinian approach
and assume that an optimized mechanism will have evolved that reduces the target Ag as quickly as possible, to minimise the
‘damage’ done, while minimising the harmful binding to self Ag in the process. The optimization problem can be solved using
mathematical tools from physics. To this end we consider all possible paths b(t), allowed by the setup in Figure 1. Any such
path will obey dbµ/dt ≥ 0 and dAT /dt ≤ 0, i.e. each will minimize AT (b) (which we will call the ‘potential energy’). The
latter is a property of the reservoir. We assume that the antibody delivery mechanism in Figure 1 has associated with it a
‘kinetic energy’ T (db/dt), which reflects the likely involvement of further variables governed by first order differential equations
(equivalently, that the equations for bµ, if autonomous, will be at least second order). The path which begins at b(t0) at time
t0 and ends in b(t1) at time t1 > t0, with AT (b(t0)) ≥ AT (b(t1)), can then be obtained (23) by minimising the action
S
(
b, ddtb
)
=
∫ t1
t0
dt L
(
b(t), ddtb(t)
)
, [6]
where L
(
b, ddtb
)
= AT (b)− T ( ddtb) is the Lagrangian (see Materials and Methods).
4 | www.pnas.org/cgi/doi/10.1073/pnas.XXXXXXXXXX Alexander Mozeika et al.
DR
AF
T
Interpretation of the action. The area under the curve of AT (b(t)) on any path b(t), given by the integral
DA (t1 − t0) =
∫ t1
t0
AT (b(t)) dt, [7]
can be seen as a damage inflicted upon the organism during the time interval [t0, t1] by the presence of free target Ag. The
intuition is that during any small time interval the damage inflicted by Ag is equal to the amount of free Ag times the time it
spends in the organism. Definition [7] assumes moreover that this damage is cumulative, i.e. exposure to a large amount of Ag
for a short time or a to a small amount of Ag for a longe time are equivalent. We observe that 0 ≤ DA ≤ AT (b(t0)) (t1 − t0),
which follows from the properties AT (b(t)) ≥ 0 and AT (b(t0)) ≥ AT (b(t1)). So the path minimising the action [6] is the path
which minimises the damage DA (t1 − t0), but subject to the constraint on db/dt enforced by the term
∫ t1
t0
dt T
( d
dtb(t)
)
in
the action (24).
Similar to [7], we can consider the integral
DS (t1 − t0) =
∫ t1
t0
dt AS(b(t)) , [8]
where 0 ≤ DS ≤ AS(b(t0)) (t1 − t0). From this integral follows the ‘damage to self’, defined for each small time interval as the
amount of free self Ag reduced by off-target action of the Abs times the duration of this reduction. Thus during the interval
[t0, t1] this damage is AS(b(t0)) (t1 − t0)−DS (t1 − t0).
Determination of optimal antibody dynamics. We minimise the action [6] subject to the constraint [8], i.e. we assume that
removal of some amount of self Ag can be tolerated. This is equivalent (24) to minimisation of [6] with the Lagrangian
L
(
b, ddtb
)
= AT (b)− T
( d
dtb
)
− γAS(b), [9]
where γ is a Lagrange parameter. The solution of the minimization is described by the Euler-Lagrange equation (see Materials
and Methods):
d
dt
∂
∂(dbµ/dt)
T
( d
dtb
)
= − ∂
∂bµ
[AT (b)− γAS(b)] . [10]
We note that the above second order differential equations that describe the optimal control of antibody release were derived
from general system level principles, with only minimal and plausible assumptions. Their solution will involve 2M constants,
fixed by the boundary conditions b(t0) and b(t1).
The natural form for the kinetic energy is T (db/dt) = 12
∑M
µ=1 Λµ(dbµ/dt)
2, where Λµ > 0. It corresponds to assuming
that at least one set of further (as yet unspecified) variables play a role in the Ab delivery process. Insertion into [10] gives us
the ‘Newtonian’ equation
Λµ
d2
dt2 bµ = AT (b) rµ(b)− γAS(b) r
S
µ (b) , [11]
where we used the affinities [2] to express the partial derivatives in [10]. We note that the Λµ, which reflect properties of the
Ab delivery mechanism, act to introduce ‘inertia’: large (small) Λµ reduce (increases) the tendency to change dbµ/dt. The
total ‘force’ Λµ(d2bµ/dt2) in [11] is a sum of a target Ag dependent term AT (b) rµ(b) that increases the rate of Ab delivery,
and a self Ag dependent term −γAS(b) rSµ (b) which decreases Ab delivery (if γ > 0). The state of mechanical equilibrium
Λµ(d2bµ/dt2) = 0, marking the balance of forces in [11], gives us, for AS(b), rµ(b) > 0, the identity
AT (b)
γAS(b)
=
rSµ (b)
rµ(b)
. [12]
It follows that there exists a function α(b) such that rµ(b) = α(b) rSµ (b) for all µ. Furthermore, for b = 0 the latter gives us
the relation rµ = α rSµ between affinities, where α = α(0).
Results
Free Ag reduced by large numbers of ‘weak’ antibodies. To proceed with our model we need to determine the dependencies of
AT and AS on the antibody amounts b = (b1, . . . , bM ). Here we consider M distinct univalent Abs Iµ, labelled by µ = 1, . . . ,M ,
each interacting with the univalent target Ag (4) and self-Ag (◦), via the following chemical reactions
◦+ Iµ
KS+µ


KS−µ
◦
Iµ 4+ Iµ
K+µ


K−µ
4
I µ [13]
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In chemical equilibrium, given the initial concentrations AT (0) of the target Ag and AS(0) of the self-Ag, the concentrations
AT (b) of free target Ag and AS(b) of self-Ag are obtained by solving the following recursive system of equations; see
Supplementary Information (SI ), Section 1A:
AT =
AT (0)
1 +
∑M
µ=1 bµ
rµ
1+AT rµ+AS rSµ
[14]
AS =
AS(0)
1 +
∑M
µ=1 bµ
rSµ
1+AT rµ+AS rSµ
. [15]
Each Ab is characterised by its affinities to the target Ag, rµ = K+µ /K−µ (the ratio of forward and backward rates), and self-Ag,
rSµ = KS+µ /KS−µ . These give rise to the affinity vectors r = (r1, . . . , rM ) and rS = (rS1 , . . . , rSM ), which define the Ab repertoire.
For multiple self-Ags the repertoire is a matrix of affinities (see SI, Sections 1A & 2A).
In order to use [11] one would prefer an explicit expression for AT (b) and AS(b), but how to solve the non-linear recursion
[14] analytically is not clear. However, if we assume that affinities scale as rµ ≡ rµ/M and rSµ ≡ rSµ/M , then in the regime
M → ∞ of having a large number of individually weak Abs, we obtain the concentrations of free Ags in explicit form (see
Materials and Methods):
AT (b) =
AT (0)
1 +B(b) , AS (b) =
AS(0)
1 +BS(b)
[16]
expressed as functions of the averages
BT (b) =
1
M
M∑
µ=1
rµ bµ, BS(b) =
1
M
M∑
µ=1
rSµ bµ.
The averages BT (b) and BS(b) can be seen as total affinities to the target Ag and the self Ag. A similar object, where bµ was
the number of B cells with affinity to Ag rµ/M , was postulated as an ‘energy’ function of somatic hypermutation in (14).
We note that the result [16], although derived for univalent Abs and Ag, is also true for multivalent Abs (see SI, Section
1B). Thus our model predicts that it is possible to reduce target antigen without requiring affinity-matured antibodies, such as
those produced in a T-dependent reaction, if a sufficient number of weaker binders are available. Furthermore, the framework
outlined here can easily incorporate multiple Ags, chemical species binding Ab-Ag complexes, phagocytes, etc. (see SI, Section
1A)
Reduced macroscopic description. Let us consider the Euler-Lagrange equations [11] for the free and self-Ag. Via [16], and
upon reverting from the right-hand side of [11] back to that of its predecessor [10], these now take the form
Λµ
d2
dt2 bµ =
AT (0)
(1 +BT )2
rµ
M
− γ AS(0)
(1 +BS)2
rSµ
M
, [17]
where BT ≡ B(b) and BS ≡ BS(b). If we assume that Λµ scales as Λµ = λµφ(M)/M , where φ(M) = o(M), we can derive for
M →∞ the following equations (SI, Section 2A):
d2
dt2BT =
AT0 |r|2
(1 +BT )2
− γA
S
0 (r · rS)
(1 +BS)2
[18]
d2
dt2BS =
AT0 (r · rS)
(1 +BT )2
− γ A
S
0 |rS |2
(1 +BS)2
,
where in the above we used the dot product definition x · y = M−1∑M
µ=1 λ
−1
µ xµyµ, with the associated norm |x| =
√
x · x.
We assume that at time t = 0 all Ab amounts and production rates are zero, i.e. bµ = dbµ/dt = 0 for all µ, so the initial
conditions for [18] are BT (0) = BS(0) = 0 and (dBT /dt)(0) = (dBS/dt)(0) = 0. Furthermore, the average Ab concentration
B˜(t) = M−1
∑M
ν=1 bν(t) is governed by the equation
d2
dt2 B˜ =
AT0 (r · 1)
(1 +BT )2
− γA
S
0 (rS · 1)
(1 +BS)2
. [19]
with the short-hand 1 = (1, . . . , 1).
The simplest case to consider is that where each Ab is either self-reactive or non-self-reactive, i.e. for each µ either rµ > 0
or rSµ > 0, but never both. This implies that r · rS = 0, and that hence [18] decouples into two independent equations:
d2
dt2BT =
AT0 |r|2
(1 +BT )2
,
d2
dt2BS = −γ
AS0 |rS |2
(1 +BS)2
[20]
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The dynamics of BT is now conservative, with energy function
E
(
BT ,
dBT
dt
)
= 12|r|2
(dBT
dt
)2
+ A
T
0
1 +BT
, [21]
where the terms (dBT /dt)2/2|r|2 and AT0 /(1 +BT ) are, respectively, the ‘kinetic’ and ‘potential’ energies. The equation for BT
describes the motion of a ‘particle’ of ‘mass’ 1/|r|2 in in a potential field (23). Furthermore, solving the energy conservation
equation E(BT , dBT /dt) = E(BT (0), (dBT /dt)(0)), for B(0) = (dBT /dt)(0) = 0, gives us
d
dtBT =
√
2AT0 |r|2
BT
(1 +BT )
. [22]
The function
√
BT /(1 +BT ) ∈ [0, 1] is monotonic increasing and concave for BT ≥ 0. Hence t B(t) is bounded from above
by
√
2AT0 |r|2 t and this bound is saturated as t → ∞. Also, the (normalised) amount of target antigen AT (b(t))/AT (0) =
(1 +BT (t))−1 is bounded from below by (1 +
√
2AT0 |r|2 t)−1.
In a similar manner we simplify the dynamics of BS , which is also conservative, describing the motion of a particle of mass
|rS |−2 and potential energy −γAS0 /(1 +BS). Here we find( d
dtBS
)2
= −2γAS0 |rS |2 BS(1 +BS) [23]
Since γ > 0 and with the assumed initial conditions, the (trivial) solution is BS = 0, i.e. self-reactive Abs are not used.
We have now seen that [20] can be mapped into equations of Classical Mechanics. The equation for BS describes the
acceleration of a particle of mass |rS |−2 in a gravitational field with gravitational constant γ, created by a another particle of
mass AS0 and radius one (23). The equation for BT has a similar interpretation but with a repulsive potential.
Ag removal is faster in a more diverse repertoire, and slower when the repertoire has higher self-reactivity. We return to the
more general case where r · rS > 0, so Abs may have the potential to bind both target Ag and self Ag. Further analytic results
can be obtained in the equilibrium regime of [18], defined by d2BT /dt2 = d2BS/dt2 = 0. This can only occur when rµ = αrSµ
for all µ (see SI, Section 2B) , where α > 0. The inverse α−1 can be seen as a degree of self-reactivity. From [17] it follows that
BT = αBS in this regime, and that [18] can be reduced to a single equation:
d2
dt2BS = A
S
0 |rS |2
[
αβ
(1 + αBS)2
− γ
(1 +BS)2
]
, [24]
with β = AT0 /AS0 . It is easy to show, using the above equation and [19], that now d2B˜/dt2 = (rS · 1)|rS |−2d2BS/dt2, and hence
the average concentration of Abs is given by
B˜ = (rS · 1)|rS |−2BS . [25]
The dynamics [24] is again conservative, now with energy
E
(
BS ,
dBS
dt
)
= 12|rS |2
(dBS
dt
)2
+ βA
S
0
1 + αBS
− γA
S
0
1 +BS
. [26]
As before we can use energy conservation, following initial conditions BS(0) = (dBS/dt)(0) = 0, to derive
d
dtBS =
√
2AS0 |rS |2
(
βαBS
1 + αBS
− γBS1 +BS
)
. [27]
From this follows the following upper bound, which is saturated as t→∞ (see SI, Section 2B):
BS(t) ≤ t/τ, [28]
with the time constant
τ = 1/|rS |
√
2AS0 (β − γ). [29]
As a consequence of [28], we find for the normalised target Ag
AT (b(t))
AT (0)
= 11 + αBS(t)
≥ 11 + αt/τ . [30]
So τ/α is a lower bound for the half-life of free target Ag; to achieve AT (b(t))/AT (0) = 12 , the required time t has to be at
least τ/α. The lower bound for the half-life of self-Ag, derived by a similar argument, is found to be τ . Furthermore, if we
define w(λ) = M−1
∑M
µ=1 λ
−1
µ then
|rS | =
√
w(λ) [σ2λ (rS) +m2λ (rS)], [31]
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where σ2λ
(
rS
)
= |rS |2/w(λ) − ((rS · 1)/w(λ))2and mλ(rS) = (rS · 1)/w(λ) are, respectively, variance and mean of the self-
affinities rS (see SI, Section 2B). Thus τ is monotonically decreasing with the variance σ2λ(rS) and the mean mλ(rS). Since
the former can be seen as a measure of the repertoire’s ‘diversity’, having a more diverse repertoire facilitates a more rapid
reduction of target Ag.
We also solved the differential equation [24] numerically for different inverse self-reactivities α. The solutions are plotted
in Supplementary Information, in Figures 5-8. Comparison of the upper bound [28] with the solutions of [24] in Figure
9 allows us to summarise various regimes. We first define, using [7], the normalised damage per unit time δA(t1 − t0) =
DA (t1 − t0) /AT (b(t0)) (t1 − t0), where 0 ≤ δA ≤ 1, and, using [8], the normalised damage to self per unit time 1−δS(t1− t0) =
1−DS (t1 − t0) /AS(b(t0)) (t1 − t0), where 0 ≤ δS ≤ 1 and 0 ≤ 1− δS ≤ 1. For the system [16], on the time interval [0, t], the
above definitions give us
δA(t) =
1
t
∫ t
0
dt′
1 + αBS(t′)
, δS(t) =
1
t
∫ t
0
dt′
1 +BS(t′)
[32]
Now since (1 + αBS)−1 is a monotonic decreasing function of BS , the upper bound [28] gives us the lower bounds
δA(t) ≥ τ
α t
log
(
1 + α t
τ
)
[33]
δS(t) ≥ τ
t
log
(
1 + t
τ
)
. [34]
The latter gives us the upper bound 1− (τ/t) log(1 + t/τ) ≥ 1− δS(t) for the damage to self.
The two bounds on damages are plotted in Figure 2 for different values of self-reactivity constant α. For a repertoire
with Abs binding α times stronger to the target Ag than to the self-Ag the immune response is ‘normal’ and ‘autoimmune’,
respectively, when α > 1 and α < 1. The normal response is characterised by a large decrease of free target Ag and a small
decrease in free self-Ag per unit of time. For the autoimmune response it is the opposite. Furthermore, the normal response is
‘accelerated’ by a larger α and increased repertoire diversity, but, for the same repertoire diversity, the autoimmune response is
slower.
Discussion
In this work we have shown, using only minimal assumptions, that antibody repertoire diversity is important in the effective
removal of antigen, in multiple ways. Not just because the repertoire will then have more chance of containing a single dominant
antibody that can react to the target-Ag, but also because for a more diverse repertoire the half life of target-Ag will be smaller.
Hence any decrease in repertoire diversity, such as that observed in older age, or caused by a prior immune response, can have
an adverse effect on the immune response to challenge. Furthermore, reduction in efficacy of central tolerance mechanisms such
as can occur in older age, will result in greater self-reactivity in the repertoire, and this too will hamper an efficient immune
response against target-Ag.
The mathematical framework in the form developed here can for now only be used to model the immune response to a finite
amount of Ag, with a fixed repertoire of Abs. Adaptation of the affinities of Abs to target Ag via affinity maturation (22) is
not yet included. To model the latter on could modify the Lagrangian [9], and derive dynamic equations for affinities. Also the
present restriction on the amount of Ag can be relaxed within the current framework, by introducing (partially stochastic) Ag
reproduction and death.
Materials and Methods
The Variational Problem.We aim to find the path b(t) that minimises the action [6] on the time-interval [t0, t1] with the boundaries
b(t0) = b0 and b(t1) = b1. This path must solve the equation δS = 0 for the difference δS = S(b+ δb, db/dt+ dδb/dt)− S(b, db/dt),
where b(t) + δb(t) is any perturbed path with δb(t0) = δb(t1) = 0 (24). Using the differential operator ∇b = (∂/∂b1, . . . , ∂/∂bM ) this
difference, up to the order O
(
|δb|2
)
, can be written in the form
δS =
∫ t1
t0
L
(
b+δb, db
dt
+δ db
dt
)
dt−
∫ t1
t0
L
(
b, db
dt
)
dt [35]
=
∫ t1
t0
{
δb.∇bL
(
b, db
dt
)
+ δ db
dt
.∇db/dtL
(
b, db
dt
)}
dt
=
[
δb .∇db/dtL
(
b, db
dt
)]t1
t0
+ · · ·
· · ·+
∫ t1
t0
δb .
{
∇bL
(
b, db
dt
)
− d
dt
∇db/dtL
(
b, db
dt
)}
dt
=
∫ t1
t0
δb .
{
∇bL
(
b, db
dt
)
− d
dt
∇db/dtL
(
b, db
dt
)}
dt
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Fig. 2. The damage due to antigen δA (lower bound), plotted as a function of the damage to self 1−δS (upper bound) for the inverse self-reactivity α = {10−3, 10−2, 10−1}
(top red curves with α increasing from top to bottom) , α = 1 (black line) and α = {10, 102, 103} (bottom blue curves with α increasing from top to bottom). The direction of
‘time’ t/τ ∈ [0,∞), indicated by arrows, is always from left to right.
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where we used integration by parts and the stated boundary conditions. Solving δS = 0 for the part of δS that is linear in δb gives us the
so-called Euler-Lagrange equation
d
dt
∇(db/dt)L
(
b, db
dt
)
= ∇bL
(
b, db
dt
)
[36]
with boundary conditions b(t0) = b0 and b(t1) = b1.
Mean-Field Limit. Here we explain briefly the derivation of [16] from [14]. Substituting rµ → rµ/M and rSµ → rSµ/M into [14] gives
AT
AT (0)
= 1
1 + 1
M
∑M
µ=1 rµbµ(1 +AT rµ/M +AS r
S
µ/M)−1
[37]
hence, if AT (0) = φ(M)AT0 and AS(0) = φ(M)AS0 , where φ(M) = o(M), i.e. limM→∞ φ(M)/M = 0, then for M →∞ we will indeed
find the mean-field expressiom [16] since
AT
AT (0)
= 1
1 + 1
M
∑M
µ=1 rµbµ +O(φ(M)/M)
[38]
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Supplementary Information
1. Chemical kinetics of antigen-antibody reactions
A. Univalent antibodies reacting with univalent antigens . We consider M different univalent antibodies (Abs), represented by the symbols
Iµ with µ ∈ {1, . . . ,M}, forming complexes with MA different univalent target antigens (Ags), 4v with v ∈ {1, . . . ,MA}, and MS self-Ags,
◦u with u ∈ {1, . . . ,MS}. The Ag bound by Ab
4v
Iµ and
◦u
Iµ will subsequently form complexes with ‘phagocytic’ species P (22). The
formation and dissociation of complexes is modelled by the four chemical reactions
◦u + Iµ
KS+µu


KS−µu
◦u
Iµ
◦u
Iµ + P
K+


K−
◦u
IµP 4v + Iµ
K+µv


K−µv
4v
Iµ
4v
Iµ + P
K+


K−
4v
Iµ P. [39]
In chemical equilibrium (25) the concentrations of free self-Ag, target Ag, Ab and P (denoted, respectively, by the symbols [◦u], [4v ], [Iµ]
and [P]) are related to the concentration of bound species
◦u
Iµ ,
◦u
IµP,
4v
Iµ and
4v
Iµ P (denoted, respectively, by the symbols [
◦u
Iµ ], [
◦u
IµP], [
4v
Iµ ]
and [
4v
Iµ P]) via the affinity parameters rSµu = KS+µu /KS−µu , rµv = K+µvK−µv and r = K+/K−, i.e. the ratios of forward/backward rates of
reactions:
rSµu =
[
◦u
Iµ ]
[◦u] [Iµ]
r = [
◦u
IµP]
[
◦u
Iµ ] [P]
rµv =
[
4v
Iµ ]
[4v ] [Iµ]
r = [
4v
Iµ P]
[
4v
Iµ ] [P]
[40]
Upon denoting the initial concentrations of the species ◦u, 4v , Iµ and P by [◦u]0, [4v ]0, [Iµ]0 and [P]0, we can use mass conservation to
write
[◦u]0 = [◦u] +
M∑
µ=1
[
◦u
Iµ ] +
M∑
µ=1
[
◦u
IµP] [41]
[4v ]0 = [4v ] +
M∑
µ=1
[
4v
Iµ ] +
M∑
µ=1
[
4v
Iµ P] [42]
[Iµ]0 = [Iµ] +
MS∑
u=1
[
◦u
Iµ ] +
MA∑
v=1
[
4v
Iµ ] +
MS∑
u=1
[
◦u
IµP] +
MA∑
v=1
[
4v
Iµ P] [43]
[P]0 = [P] +
M∑
µ=1
MS∑
u=1
[
◦u
IµP] +
M∑
µ=1
MA∑
v=1
[
4v
Iµ P] [44]
By using [40] these expressions can be written in the alternative form
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[◦u]0 = [◦u]
(
1 + (1 + r[P])
M∑
µ=1
rSµu[Iµ]
)
[45]
[4v ]0 = [4v ]
(
1 + (1 + r[P])
M∑
µ=1
rµv [Iµ]
)
[Iµ]0 = [Iµ]
(
1 + (1 + r[P])
{
MS∑
u=1
rSµu[◦u] +
MA∑
v=1
rµv [4v ]
})
[P]0 = [P]
(
1 + r
M∑
µ=1
{
MS∑
u=1
rSµu[◦u] +
MA∑
v=1
rµv [4v ]
}
[Iµ]
)
.
Finally, upon introducing the notation ASu and ATv for the concentrations [◦u] of free self Ags and [4v ] of target Ags we obtain the following
system of recursive equations, which, given the initial concentrations ASu(0) ≡ [◦u]0 and ATv (0) ≡ [4v ]0, bµ ≡ [Iµ]0 and P (0) ≡ [P]0, can
be used to obtain the equilibrium concentrations of free self and target Ag:
ASu =
ASu(0)
1 + (1 + r[P])
∑M
µ=1 r
S
µu[Iµ]
, ATv =
ATv (0)
1 + (1 + r[P])
∑M
µ=1 rµv [Iµ]
[46]
[Iµ] =
bµ
1 + (1 + r[P])
{∑MS
u=1 r
S
µuA
S
u +
∑MA
v=1 rµvA
T
v
}
[P] = P (0)
1 + r
∑M
µ=1
{∑MS
u=1 r
S
µuA
S
u +
∑MA
v=1 rµvA
T
v
}
[Iµ]
We assume that the individual antibody affinities are weak, i.e. rSµu ≡ rSµu/M and rµv ≡ rµv/M , and consider
r [P] = rP (0)
1 + r
M
∑M
µ=1
{∑MS
u=1 r
S
µuA
S
u +
∑MA
v=1 rµvA
T
v
}
[Iµ]
[47]
= rP (0)
1 + r
M
∑M
µ=1
{∑MS
u=1 r
S
µuA˜
S
uA
S
u(0) +
∑MA
v=1 rµvA˜
T
v A
T
v (0)
}
[Iµ]
,
where we have defined the normalised concentrations A˜Tv = ATv /ATv (0) and A˜Su = ASu/ASu(0), in the limit M →∞ of a ‘large’ number
of Ab types. If MA and MS are finite and ASu(0), ATv (0), P (0) ∝ φ(M), where we allow for φ(M) → ∞ as M → ∞, but such that
φ(M)/M → 0, i.e. φ(M) ∈ o(M), then
r [P] = rP0
r
M
∑M
µ=1
{∑MS
u=1 r
S
µuA˜
S
uA
0S
u +
∑MA
v=1 rµvA˜
T
v A
0T
v
}
[Iµ] + 1φ(M)
, [48]
where P (0) = φ(M)P0, ASu(0) = φ(M)A0Su and ATv (0) = φ(M)A0Tv . Thus r [P] = O(M0) when rSµu, rµv = O(M−1), MA,MS = O(M0)
and ASu(0), ATv (0), P (0) = o(M). Using the above result in our equation for [Iµ] gives
[Iµ] =
bµ
1 + (1 + r[P])
{∑MS
u=1 r
S
µuA
S
u +
∑MA
v=1 rµvA
T
v
} [49]
= bµ
1 + (1 + r[P])
{∑MS
u=1 r
S
µuA˜
S
uA
0S
u +
∑MA
v=1 rµvA˜
T
v A
0T
v
}
φ(M)
M
= bµ
(
1− (1 + r[P])
{
MS∑
u=1
rSµuA˜
S
uA
0S
u +
MA∑
v=1
rµvA˜
T
v A
0T
v
}
φ(M)
M
+O
(
φ2(M)
M2
))
= bµ +O (φ(M)/M) [50]
Inserting this into equation [48] leads us for b 6= 0 to
r [P] = rP0
r
M
∑M
µ=1
{∑MS
u=1 r
S
µuA˜
S
uA
0S
u +
∑MA
v=1 rµvA˜
T
v A
0T
v
}{
bµ +O
(
φ(M)
M
)}
+ 1
φ(M)
[51]
= P0∑MS
u=1B
S
u (b)A˜SuA0Su +
∑MA
v=1Bv(b)A˜
T
v A
0T
v + 1rφ(M) +O
(
φ(M)
rM
)
= P0∑MS
u=1B
S
u (b)A˜SuA0Su +
∑MA
v=1Bv(b)A˜
T
v A
0T
v
+O
( 1
rφ(M)
)
Here we have defined the following two macroscopic observables:
BTv (b) =
1
M
M∑
µ=1
rµv bµ, B
S
u (b) =
1
M
M∑
µ=1
rSµubµ.
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Finally, for the normalised self-Ag A˜Su = ASu/ASu(0) and the normalised target Ag A˜Tv = ATv /ATv (0) we proceed in a similar way and
obtain the equations
A˜Su =
1
1 + (1 + r[P])
∑M
µ=1 r
S
µu[Iµ]
[52]
= 1
1 + (1 + r[P]) 1
M
∑M
µ=1 r
S
µubµ +O
(
φ(M)
M
)
= 1
1+
(
1 + P0∑MS
u˜=1
BS
u˜
(b)A˜S
u˜
A0S
u˜
+
∑MA
v=1
BTv (b)A˜Tv A0Tv
)
BSu (b) +O
(
1
rφ(M)
) [53]
A˜Tv =
1
1+
(
1 + P0∑MS
u=1
BSu (b)A˜SuA0Su +
∑MA
v˜=1
BT
u˜
(b)A˜T
u˜
A0T
u˜
)
BTv (b) +O
(
1
rφ(M)
)
which for M →∞ is equivalent to the system
ASu =
ASu(0)
1+
(
1 + P (0)∑MS
u˜=1
BS
u˜
(b)AS
u˜
+
∑MA
v=1
BTv (b)ATv
)
BSu (b)
, ATv =
ATv (0)
1+
(
1 + P (0)∑MS
u=1
BSu (b)ASu+
∑MA
v˜=1
BT
v˜
(b)AT
v˜
)
BTv (b)
[54]
These expressions hold when b 6= 0. If b = 0 we simply have ASu = ASu(0) and ATv = ATv (0). We note that the affinity parameter
limit r → ∞ and the repertoire size limit M → ∞ commute. The meaning of the first limit is that the forward rate of the reaction
AbAg + P 
 AbAgP in [39] is much larger than the backward rate, i.e. K+  K−. This limit enables us to use the present equilibrium
framework to describe also irreversible processes, such as Ag ‘removal’ reactions like AbAg + P ⇀ AbAgP (26).
The equations in [54] are functions of the sum y =
∑MS
u=1B
S
uA
S
u +
∑MA
v=1B
T
v A
T
v , which satisfies the recursive equation
y =
MS∑
u=1
ASu(0)BSu
1+
(
1 + P (0)
y
)
BSu
+
MA∑
v=1
ATv (0)BTv
1+
(
1 + P (0)
y
)
BTv
[55]
= y
MS∑
u=1
ASu(0)BSu
(1 +BSu ) y + P (0)BSu
+ y
MA∑
v=1
ATv (0)BTv
(1 +BTv ) y + P (0)BTv
= y
MS∑
u=1
ASu(0)BSu
∏
u˜6=u
[(
1 +BSu˜
)
y + P (0)BSu˜
]∏
u˜
[(
1 +BSu˜
)
y + P (0)BSu˜
] + y MA∑
v=1
ATv (0)BTv
∏
v˜ 6=v
[(
1 +BTv˜
)
y + P (0)BTv˜
]∏
v˜
[(
1 +BTv˜
)
y + P (0)BTv˜
] ,
where BSu ≡ BSu (b) and BTv ≡ BTv (b). The above identity follows directly from the definition of y and [54]. Thus y is the solution of the
following polynomial equation, of order MS +MA:
MS∏
u=1
[(
1+BSu
)
y+P (0)BSu
]MA∏
v=1
[(
1+BTv
)
y+P (0)BTv
]
=
MS∑
u=1
ASu(0)BSu
∏
u˜6=u
[(
1+BSu˜
)
y+P (0)BSu˜
]
+
MA∑
v=1
ATv (0)BTv
∏
v˜ 6=v
[(
1+BTv˜
)
y+P (0)BTv˜
]
[56]
Let us assume that the relevant solution of [56] is given by the function Φ
(
BT ,BS
)
, where BT =
(
BT1 , . . . , B
T
MA
)
and BS =(
BS1 , . . . , B
S
MS
)
, so that the solution of the recursion [54] is given by
ASu
(
BT ,BS
)
=
ASu(0)Φ
(
BT ,BS
)
(1 +BSu ) Φ (BT ,BS) + P (0)BSu
, ATv
(
BT ,BS
)
=
ATv (0)Φ
(
BT ,BS
)
(1 +BTv ) Φ (BT ,BS) + P (0)BTv
[57]
and the concentrations of (total) free self-Ag and target Ag are
AS(b) =
MS∑
u=1
ASu
(
BT ,BS
)
AT (b) =
MA∑
v=1
ATv
(
BT ,BS
)
. [58]
For P (0) = 0, i.e. in the absence of binding of Ag-Ab complexes to phagocytes, the above expressions simplify significantly to
AS(b) =
MS∑
u=1
ASu(0)
1 +BSu (b)
AT (b) =
MA∑
v=1
ATv (0)
1 +BTv (b)
, [59]
so the concentration of free Ag decreases with increasing concentrations of Abs. In Figure 3 we plot the (normalised) free target Ag
concentration AT /AT (0) = 1/(1 +B(b)) against the average concentration of Abs BT (b) = M−1
∑M
µ=1 rµbµ. For P (0) > 0 we have to
compute the function Φ in [57]. Since, Φ is a solution of a polynomial of degree MA +MS [56], this could be non-nontrivial. But at least
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AT
AT (0)
BT
Figure 13: Normalised antigen, AA(0) , as a function of the average B =
1
M
PM
µ=1 rµbµ.
The e↵ect of this perturbation is to increase (or decrease) amount of available
Ag and hence it models spontaneous “birth”, ↵(t) 2 (1, b), or “death” of the Ag.
Assuming that A is a  A-homogeneous, where  A 2 R, function of epitopes6
gives us
At(b) = ↵
 A(t)A (E1(b), . . . , ENA(b)) (127)
for some real  . Furthermore, the antibody dynamics (8) is also becomes per-
turbed and is given by the equation
dbµ
dt
= ↵ µ(t)fµ ({Ei(b) : i 2 @µ}) , (128)
where we assumed that fµ is also a homogeneous function of epitopes. For
 µ > 0 the function ↵
 µ(t) is a monotonic increasing in ↵(t), so it is clear that
the increase in Ag, due to its division, leads to the increase in Abs.
Let us assume that ↵(t) = 1 + ex(t) where
⌧
dx
dt
=  ⇢x+ ⌘(t) (129)
where ⌘(t) is a zero-average Gaussian noise with h⌘(t)⌘(t0)i = 2⌧   (t   t0). For
t!1 the random variable x(t) is governed by the distribution
P (x) =
1p
2⇡/⇢ 
e 
1
2⇢ x
2
(130)
6This is mathematically convenient but what is the physical meaning of this assumption?
34
Fig. 3. Normalised free antigen concentration, AT /AT (0), as a function of the average of Ab concentrations BT (b) =M−1
∑M
µ=1
rµbµ.
for MA +MS = 2 we can compute this function analytically. Here Φ
(
BT ,BS
)
≡ Φ(BT , BS) is the solution of the quadratic equation
0 = (1 +BS) (1+B)y2 +
{
BT (1+BS) [P (0)−AT (0)] +BS(1+BT ) [P (0)−AS(0)]
}
y
+ BSBTP (0) [P (0)−AS(0)−AT (0)] . [60]
Its determinant
D =
(
BT (1+BS) [P (0)−AT (0)] +BS(1+BT ) [P (0)−AS(0)]
)2
[61]
−4BSBT (1+BS) (1+BT )P (0) [P (0)−AS(0)−AT (0)]
is positive when AT (0) +AS(0) ≥ P (0), in which case the equation has two real solutions. Only one of them is positive:
Φ(B,BS) =
BT [AT (0)−P (0)]
2 (1 +BT )
+ BS [AS(0)−P (0)]
2 (1 +BS)
[62]
+
{(
BT [AT (0)−P (0)]
2 (1 +BT )
+ BS [AS(0)−P (0)]
2 (1 +BS)
)2
+ BTBSP (0) [AT (0)+AS(0)−P (0)]
(1 +BT ) (1 +BS)
} 1
2
.
B. Bivalent Antibodies reacting with univalent target Antigen and self-Antigen. In this section we show that in the regime of ‘weak’ Abs, as
considered in previous section, the amount of free Ag is not affected by the valency of Abs (22). To this end it is sufficient only to consider
the case of bivalent Abs interacting with univalent target Ag and self-Ag. In particular we consider M different bivalent Abs, represented
by the symbols Yµ with µ ∈ {1, . . . ,M}, forming complexes with univalent target Ag, 4, and univalent self-Ag, ◦. The formation of
complexes is modelled by the following chemical reactions:
◦+ Yµ
KS+µ


KS−µ
◦
Yµ ◦+
◦
Yµ
KS+µ


KS−µ
◦ ◦
Yµ 4+ Yµ
KN+µ


KN−µ
4
Yµ [63]
4+
4
Yµ
KN+µ


KN−µ
44
Yµ ◦+
4
Yµ
KSN+µ


KSN−µ
◦4
Yµ 4+
◦
Yµ
KSN+µ


KSN−µ
4◦
Yµ [64]
In chemical equilibrium, the concentrations of free self-Ag, target Ag, and Ab, which will be denoted, respectively, by the symbols [◦], [4]
and [Yµ], are related to the concentrations of bound species
◦
Yµ,
◦ ◦
Yµ,
4
Yµ,
44
Yµ and
4◦
Yµ, which we denote, respectively, by the symbols [
◦
Yµ],
[
◦ ◦
Yµ], [
4
Yµ], [
44
Yµ] and [
4◦
Yµ], via the affinities rSµ = KS+µ /KS−µ , rNµ = KN+µ /KN−µ and rSNµ = KSN+µ /KSN−µ via
rSµ =
[
◦
Yµ]
[◦] [Yµ]
= [
◦ ◦
Yµ]
[◦] [
◦
Yµ]
rNµ =
[
4
Yµ]
[4] [Yµ]
= [
44
Yµ]
[4] [
4
Yµ]
rSNµ =
[
4◦
Yµ]
[4][
◦
Yµ]
= [
◦4
Yµ]
[◦][
4
Yµ]
. [65]
Alexander Mozeika et al. PNAS | October 30, 2019 | vol. XXX | no. XX | 13
DR
AF
T
If the initial concentrations of species ◦, 4 and Yµ are, respectively, given by [◦]0, [4]0 and [Yµ]0 then, because of the mass conservation,
we have
[◦]0 = [◦] +
M∑
µ=1
[
◦
Yµ] +
M∑
µ=1
[
◦4
Yµ] +
M∑
µ=1
[
4◦
Yµ] + 2
M∑
µ=1
[
◦ ◦
Yµ] [66]
[4]0 = [4] +
M∑
µ=1
[
4
Yµ] +
M∑
µ=1
[
◦4
Yµ] +
M∑
µ=1
[
4◦
Yµ] + 2
M∑
µ=1
[
44
Yµ]
[Yµ]0 = [Yµ] + [
◦
Yµ] + [
4
Yµ] + [
◦4
Yµ] + [
4◦
Yµ] + [
◦ ◦
Yµ] + [
44
Yµ].
Using the equilibrium relations [65] in the above three lines now gives us
[◦] = [◦]0
1 +
∑M
µ=1
[
rSµ + rSNµ [4]
(
rSµ + rNµ
)
+ 2rSµ
2 [◦]
]
[Yµ]
[67]
[4] = [4]0
1 +
∑M
µ=1
[
rNµ + rSNµ [◦]
(
rSµ + rNµ
)
+ 2rNµ
2 [4]
]
[Yµ]
,
where
[Yµ] =
[Yµ]0
1 + rSµ [◦] + rNµ [4] + rSNµ [◦] [4]
{
rSµ + rNµ
}
+ rSµ
2 [◦]2 + rNµ 2 [4]2
. [68]
Finally, with the notation AS = [◦], AS(0) = [◦]0, AT = [4], AT (0) = [4]0 and bµ = [Yµ]0, we obtain the recursive equations
AS =
AS(0)
1 +
∑M
µ=1
[
rSµ+rSNµ (rSµ+rNµ )AT+2rSµ2AS
]
bµ
1+rSµAS+rNµ AT+rSNµ {rSµ+rNµ }ASAT+rSµ2A2S+rNµ 2A2T
[69]
AT =
AT (0)
1 +
∑M
µ=1
[
rNµ +rSNµ (rSµ+rNµ )AS+2rNµ 2AT
]
bµ
1+rSµAS+rNµ AT+rSNµ {rSµ+rNµ }ASAT+rSµ2A2S+rNµ 2A2T
.
Now let us redefine rµ = rµ/M , rSµ = rSµ/M and rSNµ = rSNµ /M , and consider the relevant term in our expression for AS :[
rSµ + rSNµ
(
rSµ + rNµ
)
AT + 2rSµ
2
AS
]
bµ
1 + rSµAS + rNµ AT + rSNµ
{
rSµ + rNµ
}
ASAT + rSµ
2A2S + rNµ
2A2T
[70]
=
rSµ
M
bµ +
[
rSNµ
(
rSµ + rNµ
)
AT + 2rSµ
2
AS
]
bµ
M2
1 +
[
rSµAS + rNµ AT
]
1
M
+
[
rSNµ
{
rSµ + rNµ
}
ASAT + rSµ
2A2S + rNµ
2A2T
]
1
M2
=
rSµ bµ
M
+O
(
φ2(M)/M2
)
Here we assumed that AS , A ∝ φ(M), where φ(M) = o(M). The same argument applies to the corresponding term in the equation for
AT , giving us rµbµ/M +O
(
φ2(M)/M2
)
and hence
AS(b) =
AS(0)
1 + 1
M
∑M
µ=1 r
S
µ bµ
AT (b) =
AT (0)
1 + 1
M
∑M
µ=1 r
N
µ bµ
[71]
for M →∞, so we recover the result [59] for univalent Abs interacting with two types of Ag. The above argument easily generalises to
include multiple univalent Ags and binding of Ag-Ab complexes.
2. Analysis of Antibody Dynamics
In this section we study the Euler-Lagrange equation
Λµ
d2
dt2
bµ = − ∂
∂bµ
[AT (b)− γAS(b)] , [72]
where Λµ ≥ 0 and γ ≥ 0, with the ‘energy’ functions AT (b) and AS(b) derived in section A.
A. Binding of univalent Antigens by univalent Antibodies in the presence of univalent self-Antigens. Let us define the total potential ‘energy’
Aγ
(
BT ,BS
)
= AT
(
BT ,BS
)
− γAS
(
BT ,BS
)
, [73]
where AT
(
BT ,BS
)
≡ AT (b) and AS
(
BT ,BS
)
≡ AS(b), with AT (b) and AS(b) as defined in [58], and we consider equation [72] for
this energy function:
Λµ
d2
dt2
bµ = − ∂
∂bµ
Aγ
(
BT ,BS
)
= −
MA∑
k=1
∂Aγ
∂BT
k
∂BTk
∂bµ
−
MS∑
`=1
∂Aγ
∂BS
`
∂BS`
∂bµ
= −
MA∑
k=1
∂Aγ
∂BT
k
rµk
M
−
MS∑
`=1
∂Aγ
∂BS
`
rSµ`
M
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b1
bµ
bM
A
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rSµ
AS
Figure 6: Network of M di↵erent populations of univalent antibodies (small
blue circles) interacting with populations of the univalent antigen (red triangle)
and self-antigen (blue circle). Population of the antibody µ is interacting with
the antigen and self-Ag with, respectively, the ‘strength’ rµ, i.e. a nity , and
rSµ . Population of antigens is interacting with all antibodies.
Let us define the averages B(t) = 1M
PM
⌫=1 r⌫ b⌫(t) and BS(t) =
1
M
PM
⌫=1 r
S
⌫ b⌫
then above equation gives the closed system of equations
B¨ =
A(0)|r|2
(1 +B)
2    
AS(0)hr, rSi
(1 +BS)
2 (70)
B¨S =
A(0)hr, rSi
(1 +B)
2    
AS(0)|rS |2
(1 +BS)
2 ,
where in above we used the definition of inner product (58) to represent averages
such as 1M
PM
µ=1 rµr
S
µ/ µ etc., with the set of initial conditions {B˙(0), B˙S(0), B(0), BS(0)}.
We note that the ’observable’B(t) = 1M
PM
⌫=1 r⌫ b⌫(t) andBS(t) =
1
M
PM
⌫=1 r
S
⌫ b⌫(t)
can be computed from the a nities rµ and r
S
µ of the Ab µ measured indepen-
dently from the other Ab’s. Furthermore, the observable B˜(t) = 1M
PM
⌫=1 b⌫(t)
is governed by the equation
¨˜B =
A(0)hr,1i
(1 +B)
2    
AS(0)hrS,1i
(1 +BS)
2 . (71)
The simplest case to consider is when each Ab is either self-reactive or non-
self-reactive, i.e. for Ab µ either the a nity to non-self rµ = 0 and self r
S
µ > 0
or the a nity rµ > 0 and r
S
µ = 0. The latter implies that hr, rSi = 0, in the
system of equations (70), giving us the two equations
B¨ =
A(0)|r|2
(1 +B)
2 (72)
B¨S =   AS(0)|r
S |2
(1 +BS)
2
22
Fig. 4. Network representation of M different populations of univalent Abs (small blue circles) interacting with populations of univalent target Ag (red triangle) and self-Ag (large
blue circle). Ab µ is interacting with the target Ag and self-Ag with, strengths (affinities) rµ and rSµ , respectively. The Ags are interacting with all Abs.
Assuming that Λµ = λµφ(M)/M , where φ(M) = o(M), and using definition [52] above, allows us to derive the following equations for the
set of macroscopic observables BT and BS :
d2
dt2
BTv = −
MA∑
k=1
(rv · rk)
∂
∂BT
k
Aγ
(
BT,BS
)
−
MS∑
`=1
(rv · rS` )
∂
∂BS
`
Aγ
(
BT,BS
)
[74]
d2
dt2
BSu = −
MA∑
k=1
(rSu · rk)
∂
∂BT
k
Aγ
(
BT,BS
)
−
MS∑
`=1
(rSu · rS`
∂
∂BS
`
Aγ
(
BT,BS
)
[75]
with the short-hand x · y = M−1
∑M
µ=1 λ
−1
µ xµyµ, with associated inner product norm |x| =
√
x · x.
In the special simplified case where each Ab µ interacts with only one type of Ag, we will have rv · rk = 0 if v 6= k, rv · rS` = 0, etc.,
and the system of equations [74] simplifies to
1
|rv |2
d2
dt2
Bv = − ∂
∂Bv
Aγ
(
B,BS
) 1
|rSu |2
d2
dt2
BSu = −
∂
∂BSu
Aγ
(
B,BS
)
.
We note that the above simplified macroscopic dynamics is conservative (23), with the energy function
E
(
BT, d
dt
BT ;BS, d
dt
BS
)
=
MA∑
v=1
1
2|rv |2
(dBTv
dt
)2
+
MS∑
u=1
1
2|rSu |2
(dBSu
dt
)2
+Aγ
(
BT ,BS
)
[76]
where the first two terms play the role of ‘kinetic’ energies, and the third term is the ‘potential’ energy. The factors 1/|rv |2 and 1/|rSu |2
can be seen as ‘masses’. So [76] describes the otion (23) of MA +MS ‘particles’, with distinct masses, in a potential field with potential
energy [73].
Let us now assume that the numbers of target and self Ags are equal, i.e. MA = MS , and that each Ab µ simultaneously interacts with
two types of Ag, one target and one self (see Figure 4 for MA = MS = 1). Then the affinity vectors rv and rSu satisfy the orthogonality
conditions rv · rk = 0 if k 6= v and rSu · rS` = 0 if ` 6= u, i.e. each row in the affinity matrices RT = (r1, . . . , rMA ) and RS = (rS1 , . . . , rSMA )
has exactly one positive component. Also rv · rS` = 0 if ` 6= u, so, up to a permutation of columns, the matrices RT and RS are the same.
Our equations then simplify to
d2
dt2
BTv = −
∂
∂BTv
Aγ
(
BT,BS
)
|rv |2 − ∂
∂BSu
Aγ
(
BT,BS
)
(rv · rSu) [77]
d2
dt2
BSu = −
∂
∂BTv
Aγ
(
BT,BS
)
(rSu · rv)−
∂
∂BSu
Aγ
(
BT,BS
)
|rSu |2. [78]
Assuming that the above system is in ‘mechanical’ equilibrium, d2BTv /dt2 = d2BSu /dt2 = 0, leads us to the two equalities
−
∂Aγ
(
BT,BS
)
/∂BTv
∂Aγ (BT,BS) /∂BSu
= (rv · r
S
u)
|rv |2
−
∂Aγ
(
BT,BS
)
/∂BTv
∂Aγ (BT,BS) /∂BSu
= |r
S
u |2
(rSu · rv)
[79]
and hence
(rv · rSu)2 = |rSu |2|rv |2. [80]
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We note that this will be true if and only if r = α(v, u)rSu , for some α(v, u) > 0. Using this in [77] gives us the equations
d2
dt2
Bv = − ∂
∂Bv
Aγ
(
B,BS
)
α2(v, u)|rSu |2 −
∂
∂BSu
Aγ
(
B,BS
)
α(v, u)|rSu |2 [81]
d2
dt2
BSu = −
∂
∂Bv
Aγ
(
B,BS
)
α(v, u)|rSu |2 −
∂
∂BSu
Aγ
(
B,BS
)
|rSu |2
We note that α(v, u) generates a mapping rv = α(v, u) rSu between the affinities rv and rSu . Without loss of generality, we can always
re-label the antibodies such that u = v, so that we only need α(v, v) ≡ α(v). Equation [81] can then be simplified to
1
α(v)|rSv |2
d2
dt2
BTv = −
∂
∂BTv
Aγ
(
BT,BS
)
α(v)− ∂
∂BSv
Aγ
(
BT,BS
)
[82]
1
|rSv |2
d2
dt2
BSv = −
∂
∂BTv
Aγ
(
BT,BS
)
α(v)− ∂
∂BSv
Aγ
(
BT,BS
)
.
Furthermore, since now BTv = α(v)BSv the above reduces to the single equation
1
|rSv |2
d2
dt2
BSv = −α(v)
∂
∂BTv
Aγ
(
BT ,BS
)
− ∂
∂BSv
Aγ
(
BT ,BS
)
, [83]
where the partial derivatives are evaluated at BTv = α(v)BSv .
The macroscopic dynamics [83] is conservative when P (0) = 0. In this case the potential energy [73] is given by
Aγ
(
BT,BS
)
=
MA∑
v=1
ATv (0)
1 +BTv
− γ
MS∑
u=1
ASu(0)
1 +BSu
[84]
and equation [83] reduces to
1
|rSv |2
d2
dt2
BSv = −
∂
∂BSv
{
A0Tv
1 + α(v)BSv
− γ A
0S
v
1 +BSv
}
, [85]
so this dynamics is conservative, with the energy
Ev
(
BSv ,
d
dt
BSv
)
= 1
2|rSv |2
( d
dt
BSv
)2
+ A
0T
v
(1 + α(v)BSv )
− γ A
0S
v
(1 +BSv )
, [86]
describing the ‘motion’ a ‘particle’ of ‘mass’ 1/|rSv |2 in a potential field. If at time t = 0 we are given the initial position BSv (0) and
velocity (dBSv /dt)(0) of this particle, then for all t > 0 we have due to energy conservation:
Ev
(
BSv ,
d
dt
BSv
)
= Ev
(
BSv (0), (
d
dt
BSv )(0)
)
. [87]
B. Binding of univalent Antigen by univalent Antibodies in the presence of univalent self-Antigen. The dynamics [72] with the energy function
[84] can be solved in a full detail when MA = MS = 1 (see Figure 4). Here the Euler-Lagrange equation is
Λµ
d2
dt2
bµ = − ∂
∂bµ
[
AT (0)
1 +BT (b)
− γ AS(0)
1 +BS(b)
]
[88]
= AT (0)
(1 +BT (b))2
rµ
M
− γ AS(0)
(1 +BS(b))2
rSµ
M
,
where BT (b) = M−1
∑M
ν=1 rν bν(t) and BS(b) = M
−1∑M
ν=1 r
S
ν bν . The latter two macroscopic observables are governed by the
equations
d2
dt2
B =
A0T |r|2
(1 +BT )2
− γ A
0
S(r · rS)
(1 +BS)2
d2
dt2
BS =
A0T (r · rS)
(1 +BT )2
− γ A
0
S |rS |2
(1 +BS)2
, [89]
where BT ≡ B(b) and BS ≡ BS(b), with initial conditions {(dBT /dt)(0), (dBS/dt)(0), BT (0), BS(0)}. So the above equations are a
special case of [74,75]. Furthermore, the average concentration of Abs B˜(b) = M−1
∑M
ν=1 bν is governed by
d2
dt2
B˜ =
A0T (r · 1)
(1 +BT )2
− γ A
0
S(rS · 1)
(1 +BS)2
. [90]
The simplest case is that where each Ab is either self-reactive or non-self-reactive (never both), i.e. for all µ either rµ = 0 and rSµ > 0
or rµ > 0 and rSµ = 0. This implies that (r · rS) = 0 in [89], giving us the two independent equations
d2
dt2
BT =
A0T |r|2
(1 +BT )2
d2
dt2
BS = −γ
A0S |rS |2
(1 +BS)2
. [91]
We note that above is a special case of [76], so the dynamics of BT is conservative with the energy
E
(
BT ,
d
dt
BT
)
= 1
2|r|2
( d
dt
BT
)2
+
A0T
1 +BT
, [92]
Since energy is conserved, one can then use the identity E(BT , dBT /dt) = E (BT (0), (dBT /dt)(0)) to obtain a simple equation for dB/dt.
For the initial conditions (dBT /dt)(0) = BT (0) = 0 this equation is given by
d
dt
BT =
√
2A0T |r|2
BT
1 +BT
. [93]
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The function
√
B/(1+B) ∈ [0, 1] is monotonic increasing and concave for B ∈ [ 0,∞). Hence BT (t) is bounded from above by
√
2A0|r|2 t,
saturating this upper bound as t → ∞. Furthermore, the (normalised) amount of antigen AT /A(0) = 1/(1+BT (t)) is bounded from
below by 1/(1+
√
2A0|r|2) t. Also the dynamics of BS in [91] is conservative, with energy
E
(
BS ,
d
dt
BS
)
= 1
2|rS |2
( d
dt
BS
)2
− γA
0
S
1 +BS
, [94]
and using E(BS , dBS/dt) = E(BS(0), (dBS/dt)(0)), with initial conditions (dBS/dt)(0) = BS(0) = 0, gives us the equation( d
dt
BS
)2
= −2γA0S |rS |2
BS
1 +BS
[95]
which for γ > 0 has only the trivial solution BS = 0. Values γ < 0 lead to self-antigen removal and hence are not desirable.
Further results for [89] can in equilibrium states, defined by d2BT /dt2 = d2BS/dt2 = 0. From these conditions we infer that
(r · rS)2 = r2(rS)2, hence rµ = α rSµ for some α > 0. This, in return, via the definitions of BT and BS , implies BT = αBS and hence the
system [89] reduces to a single equation:
d2
dt2
BS = A0S |rS |2
[
αβ
(1 + αBS)2
− γ
(1 +BS)2
]
, [96]
where we defined β = A0T /A
0
S . Furthermore, for equation [90], governing the average concentration of antibodies B˜, we obtain
d2
dt2
B˜ = A0S(rS · 1)
[
αβ
(1 + αBS)2
− γ
(1 +BS)2
]
. [97]
Thus the two equations [96] and [97] are related according to |rS |2d2B˜/dt2 = (rS · 1)d2BS/dt2, and hence
B˜ = [(rS · 1)/|rS |2]BS . [98]
The dynamics [96] conserves the energy
E
(
BS ,
d
dt
BS
)
= 1
2|rS |2
( d
dt
BS
)2
+A0S
[
β
(1 + αBS)
− γ
(1 +BS)
]
[99]
and we can use E (BS , dBS/dt) = E (BS(0), (dBS/dt)(0)) to obtain
d
dt
BS =
√( d
dt
BS(0)
)2
+ 2A0S |rS |2
[
γ
1 +BS
− β
1 + αBS
−
(
γ
1 +BS(0)
− β
1 + αBS(0)
)]
. [100]
Let us assume that BS(0) = (dBS/dt)(0) = 0 then this simplifies to
d
dt
BS =
√
2A0S |rS |2
(
γ
1 +BS
− β
1 + αBS
− γ + β
)
. [101]
The argument of the square root above is non-negative if
αβ/γ ≥ (1+αBS)/(1+BS), [102]
equivalently, if γ/(1 +BS)− β/(1 + αBS)− γ + β ≥ 0. We note that for the BS = 0 and BS =∞ this inequality reduces to αβ ≥ γ and
β ≥ γ, respectively. The right hand side of [102] is monotonically increasing on the interval BS ∈ [ 0,∞) when α > 1, and monotonically
decreasing if α < 1. Hence we need to satisfy β ≥ γ when α > 1, and αβ ≥ γ when α < 1. The RHS of [101] is a monotonic increasing
function of BS when
β/α > γ for α > 1, and αβ > γ for α < 1 [103]
Taking the limit BS →∞ in the right hand side of [101] gives us
d
dt
BS =
√
2A0S |rS |2 (β − γ) [104]
and hence
BS(t) =
√
2A0S |rS |2 (β − γ) t+ const. [105]
If the above monotonicity condition [103] is satisfied, then
BS(t) ≤ t/τ , [106]
where τ is the time constant
τ = 1/
√
2A0S |rS |2 (β − γ). [107]
Furthermore, for α > 1 the RHS of [101] has a has a maximum at
B∗S =
α(β − γ) + (α− 1)
√
αβγ
α(αγ − β) , [108]
when
β/α < γ ≤ β, [109]
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Figure 7: The (average) amount of antibodies, BS , rate B˙S and (normalised)
antigen A, (top blue curve is the self-antigen and bottom red curve is the anti-
gen) plotted as a function of time t for AS(0) |rS |2 = 10, ↵ = 10,   = 0.01 and
  = 0.0009.
Taking the limit BS !1 in the RHS of (94) gives us
B˙S =
q
2AS(0) |rS |2 (     ) (98)
and hence
BS(t) =
q
2AS(0) |rS |2 (     ) t+ const.. (99)
If the condition in (97) is satisfied then
BS(t) = c t, (100)
where c =
p
2AS(0) |rS |2 (     ), is an upper bound for the solution of (94).
Furthermore, for ↵ > 1 the RHS of (94) has a has a maximum at
B⇤S =
↵(     ) + (↵  1)p↵  
↵(↵     ) , (101)
when
 
↵
<     , (102)
which gives us the upper bound (100) with
c =
s
2AS(0) |rS |2
✓
 
(1 +B⇤S)
   
(1 + ↵B⇤S)
+ (     )
◆
. (103)
We solve the equation (83) numerically in the regimes (97) and (102) for a
given  , AS(0)|rS |2. The solutions of this equation are plotted in Figures 7–10.
Also we compare the upper bound (100) with a solution of (83) in Figure 11.
The upper bound allows us to summarise various regimes of the univalent Ag
binding experiment in one ‘figure as follows.
Let us now consider the normalised version
 A(t2   t1) = 1
A(b(t1)) (t2   t1)
Z t2
t1
A(b(t˜)) dt˜, (104)
26
Fig. 5. The average Ab concentration, BS , and the rate B˙S = dBS/dt and (normalised) Ag A (top blue curve: self-Ag; bottom red curve: target Ag), shown as functions of
time t for A0S |rS |2 = 10, α = 10, β = 0.01 and γ = 0.0009.
BS B˙S A
t
Figure 8: The (average) amount of antibodies, BS , rate B˙S and (normalised)
antigen A, (top blue curve is the self-antigen and bottom red curve is the anti-
gen) plotted as a function of time t for AS(0) |rS |2 = 10, ↵ = 10,   = 0.01 and
  = 0.009.
BS B˙S A
t
Figure 9: The (average) amount of antibodies, BS , rate B˙S and (normalised)
antigen A, (top blue curve is the self-antigen and bottom red curve is the anti-
gen) plotted as a function of time t for AS(0) |rS |2 = 10, ↵ = 1,   = 0.01 and
  = 0.009.
where 0   A  1, of the damage (12) and the normalised version
 S(t2   t1) = 1
AS(b(t1)) (t2   t1)
Z t2
t1
AS(b(t˜)) dt˜, (105)
where 0   S  1, of (17). The latter gives us the (normalised) self-damage
0  1  S  1. For the mean field system (??), on the time interval [0, t], above
gives us
 A(t) =
1
t
Z t
0
1 
1 + ↵BS(t˜)
  dt˜ (106)
and
 S(t) =
1
t
Z t
0
1 
1 +BS(t˜)
  dt˜. (107)
We note that 1(1+↵BS) is a monotonic decreasing function of BS and hence
27
Fig. 6. The average Ab concentration, BS , and the rate B˙S = dBS/dt and (normalised) Ag A (top blue curve: self-Ag; bottom red curve: target Ag), shown as functions of
time t for A0S |rS |2 = 10, α = 10, β = 0.01 and γ = 0.009.
So here the time constant in [106] is different, and given by
τ = 1√
2A0S |rS |2
(
γ
1+B∗
S
− β1+αB∗
S
+ β − γ
) . [110]
We solve equation [96] numerically in the regimes [103] and [109], for a given values of β and A0S |rS |2. The solutions are plotted in
Figures 5–8. Also we compare the upper bound [106] with a typical solution of [96] in Figure 9.
Let us now consider the normalised damage per unit of time
δA(t1 − t0) = 1
A(b(t0)) (t1 − t0)
∫ t1
t0
dt′ A(b(t′)), [111]
where 0 ≤ δA ≤ 1, and a similar integral
δS(t1 − t0) = 1
AS(b(t0)) (t1 − t0
∫ t1
t0
dt′ AS(b(t′)), [112]
where 0 ≤ δS ≤ 1, which defines the (normalised) self-damage per unit of time 1− δS , where 0 ≤ 1− δS ≤ 1. For the scenario described
by the equation [96], on the time interval [0, t], the above expressions give us
δA(t) =
1
t
∫ t
0
dt′ 1
1 + αBS(t′)
, δS(t) =
1
t
∫ t
0
dt′ 1
1 +BS(t′)
. [113]
Since 1/(1 +αB) decreases monotonically with B, from BS(t) < t/τ we obtain for the regime [103] the two lower bounds
δA(t) ≥ δ∗A(t) =
τ
αt
log
(
1 + α t
τ
)
δS(t) ≥ δ∗S(t) =
τ
t
log
(
1 + t
τ
)
, [114]
with the time constant
τ−1 =
√
2A0S |rS |2 (β − γ), [115]
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Figure 10: The (average) amount of antibodies, BS , rate B˙S and (normalised)
antigen A, (top blue curve is the self-antigen and bottom red curve is the anti-
gen) plotted as a function of time t for AS(0) |rS |2 = 10, ↵ = 0.1,   = 0.01 and
  = 0.009.
BS A
t
Figure 11: Left: The (average) amount of antibodies, BS , (blue line) and upper
bound (black line) plotted as a function of time t for ↵ = 10 and   = 0.009.
Middle: The (normalised) antigen, A, (the top ‘blue’ curves is self-antigen and
the bottom ‘red’ curves is antigen) and the lower bound plotted as a function of
time t for ↵ = 10 and   = 0.009. Right: The antigen and the lower bound (top
‘red’ curves is antigen and the bottom ‘blue’ curves is self-antigen) plotted as a
function of time t for ↵ = 0.1 and   = 0.0009. The   = 0.01 and AS(0) |rS |2 =
10.
BS(t) = c t gives us the lower bounds
 A(t)    ⇤A(t) =
1
↵c t
log (1 + ↵c t) (108)
and
 S(t)    ⇤S(t) =
1
c t
log (1 + c t) , (109)
with the ‘time’ constant
c =
q
2AS(0) |rS |2 (     ), (110)
for the regime in (97).
Let us consider the function  ⇤(x) = 1x log(1 + x) in the domain x 2 (0,1).
The derivative of this function  ⇤0(x) = x (1+x) log(1+x)(1+x)x2 , by the inequality
28
Fig. 7. The average Ab concentrations , BS , and the rate B˙S and (normalised) Ag A (top blue curve: self-Ag; bottom red curve: target Ag), shown as functions of time t for
A0S |rS |2 = 10, α = 1, β = 0.01 and γ = 0.009.
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Figure 10: The (average) amount of antibodies, BS , rate B˙S and (normalised)
antigen A, (top blue curve is the self-antigen and bottom red curve is the anti-
gen) plotted as a function of time t for AS(0) |rS |2 = 10, ↵ = 0.1,   = 0.01 and
  = 0.009.
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Figure 11: Left: The (average) amount of antibodies, BS , (blue line) and upper
bound (black line) plotted as a function of time t for ↵ = 10 and   = 0.009.
Middle: The (normalised) antigen, A, (the top ‘blue’ curves is self-antigen and
the bottom ‘red’ curves is antigen) and the lower bound plotted as a function of
time t for ↵ = 10 and   = 0.009. Right: The antigen and the lower bound (top
‘red’ curves is antigen and the bottom ‘blue’ curves is self-antigen) plotted as a
function of time t for ↵ = 0.1 and   = 0.0009. The   = 0.01 and AS(0) |rS |2 =
10.
BS(t) = c t gives us the lower bounds
 A(t)    ⇤A(t) =
1
↵c t
log (1 + ↵c t) (108)
and
 S(t)    ⇤S(t) =
1
c t
log (1 + c t) , (109)
with the ‘time’ constant
c =
q
2AS(0) |rS |2 (     ), (110)
for the regime in (97).
Let us consider the function  ⇤(x) = 1x log(1 + x) in the domain x 2 (0,1).
The derivative of this function  ⇤0(x) = x (1+x) log(1+x)(1+x)x2 , by the inequality
28
Fig. 8. The average Ab concentrations, BS , and the rate B˙S and (normalised) Ag A (top blue curve: self-Ag; bottom red curve: target Ag), shown as functions of time t for
A0S |rS |2 = 10, α = 0.1, β = 0.01 and γ = 0.009.
Let us consider the function δ∗(x) = x−1 log(1 + x) for x ∈ (0,∞). Its derivative is δ∗′(x) = [x− (1 + x) log (1 + x)][(1 + x)x2]. Due
to the inequality log (1 + x) ≥ 1− (1 + x)−1, this derivative is negative for any finite x, so δ∗(x) is a monotonic decreasing function with
δ∗(x)→ 1 as x→ 0 and δ∗(x)→ 0 as x→∞. Since the image of δ∗(x) is the interval [0, 1] the function 1− δ∗(x) is monotonic increasing
on the same domain. It follows that δ∗A(t)→ 1 as t→ 0, implying that the (normalised) damage δA(t)→ 1 in this limit, and δ∗A(t)→ 0 as
t→∞. Also 1− δ∗S(t)→ 0 as t→ 0, implying that the self-damage 1− δS(t)→ 0 in this limit, and 1− δ∗S(t)→ 1 as t→∞. For α = 1
(where the strengths of antib dy interaction with non-self and self are identical) we obtain δ∗A = δ
∗
S and the damage δ
∗
A (lower bound) is
linearly related to the self-damage he self-damage 1− δ∗S (upper bound) via δ∗A = 1− (1− δ∗S). For α < 1 (where the strength of antibody
interaction with self is greater than the interaction with non-self) we obtain δ∗A > 1− (1− δ∗S), so for a small reduction in the damage δ∗A
we find a large increase in the damage to self 1− δ∗S . For α > 1 (where the strength of antibody interaction with non-self is greater than
the interaction with self) we obtain δ∗A < 1− (1− δ∗S), i.e. for a large reduction in δ∗A we have a small increase in 1− δ∗S .
We (re-)label the antibodies such that λ1 ≤ λ2 ≤ · · · ≤ λM . We define the mean and the variance of the binding strengths to
self-antigen, m(rS) = M−1
∑M
µ=1 r
S
µ and σ2(rS) = M−1
∑M
µ=1(r
S
µ )2 − (M−1
∑M
µ=1 r
S
µ )2, and consider |rS |2 = M−1
∑M
µ=1 λ
−1
µ (rSµ )2.
We note that for λµ = λ:
λ |rS |2 = σ2(rS) +m2(rS), [116]
Thus the time constant τ is given by
1/τ(λ) =
√
2AS(0)λ−1 [σ2(rS) +m2(rS)] (β − γ) [117]
Second, the weighted average M−1
∑M
µ=1 λ
−1
µ
(
rSµ
)2, with λ−1µ ≥ 0 for all µ, is bounded from below by λ−1M M−1∑Mµ=1(rSµ )2 and from
above by λ−11 M−1
∑M
µ=1(r
S
µ )2. H nce the time constant i [115] is bounded according to
τ(λ1) ≤ τ(λ) ≤ τ(λM ) [118]
This fact, in combination with the monotonicity of the x−1 log(1 + x) as it appears in [114], gives us new lower bounds on the damage to
non-self and the damage self:
δA(t) ≥ τ (λ1)
α t
log
(
1 + α t
τ (λ1)
)
δS(t) ≥ τ (λ1)
t
log
(
1 + t
τ (λ1)
)
[119]
We note that, since the time constant τ controls the speed of antigen removal, see equation [101], this speed is a monotonic increasing
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Figure 10: The (average) amount of antibodies, BS , rate B˙S and (normalised)
antigen A, (top blue curve is the self-antigen and bottom red curve is the anti-
gen) plotted as a function of time t for AS(0) |rS |2 = 10, ↵ = 0.1,   = 0.01 and
  = 0.009.
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Figure 11: Left: The (average) amount of antibodies, BS , (blue line) and upper
bound (black line) plotted as a function of time t for ↵ = 10 and   = 0.009.
Middle: The (normalised) antigen, A, (the top ‘blue’ curves is self-antigen and
the bottom ‘red’ curves is antigen) and the lower bound plotted as a function of
time t for ↵ = 10 and   = 0.009. Right: The antigen and the lower bound (top
‘red’ curves is antigen and the bottom ‘blue’ curves is self-antigen) plotted as a
function of time t for ↵ = 0.1 and   = 0.0009. The   = 0.01 and AS(0) |rS |2 =
10.
BS(t) = c t gives us the lower bounds
 A(t)    ⇤A(t) =
1
↵c t
log (1 + ↵c t) (108)
and
 S(t)    ⇤S(t) =
1
c t
log (1 + c t) , (109)
with the ‘time’ constant
c =
q
2AS(0) |rS |2 (     ), (110)
for the regime in (97).
Let us consider the function  ⇤(x) = 1x log(1 + x) in the domain x 2 (0,1).
The derivative of this function  ⇤0(x) = x (1+x) log(1+x)(1+x)x2 , by the inequality
28
Fig. 9. Left: The average of Ab concentrations , BS , (blue line) and upper bound (black line) as a function of time t for α = 10 and γ = 0.009. Middle: The (normalised) Ag,
A, (blue (cyan) curve is self-Ag and red (magenta) curve is target Ag) and the lower bound as a function of time t for α = and γ = 0.009. Right: Ag and the lower bound
(red (magenta) curve is target Ag and blue (cyan) curve is self-Ag) as a function of time t for α = 0.1 and γ = 0.0009. The β = 0.01 and A0S |rS |2 = 10.
function of the varianc σ2(rS) and the mean m(rS) of the vector of affiniti s rS , .e. of the antibody repertoire. Thus, having a repertoire
with a higher variance facilitates a more rapid Ag removal.
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